The antiviral properties of flavonoids
Clinical Traditional Medicine and Pharmacology · 2025-03 · 6 (1) · 200192
DOI: 10.1016/j.ctmp.2024.200192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Traditional Medicine and Pharmacology, 2025-03. Verfasst von Jing Chen und 5 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Enteroviruses belong to the Picornaviridae family, which is a type of non-enveloped RNA virus. They encompass numerous members and exhibit high rates of mutation and recombination, leading to the emergence of new pathogenic viral strains. In addition to their primary route of infection through the gastrointestinal and upper respiratory tracts, enteroviruses can also infect other tissues such as neurons or muscles, resulting in severe clinical manifestations within the nervous system. Flavonoids, natural compounds found in plants, have shown significant potential as antiviral agents, particularly against enteroviruses, a group of pathogens responsible for various human diseases. This review aims to summarize the recent progress of flavonoids in anti-enterovirus research, reveal their potential mechanisms, and explore their application prospects. A literature search was conducted across multiple databases, including PubMed and Scopus, from 2004 to 2024 using the keywords "Flavonoid" and "Enterovirus". Relevant studies and reviews were identified and subsequently selected for analysis and discussion. A large body of research indicate that flavonoids exhibited antiviral activity against enteroviruses through multiple mechanisms, including blocking viral entry, inhibiting viral replication, and suppressing viral protease activity. Prominent flavonoids such as quercetin, baicalein, and luteolin exhibit significant antiviral potential in vivo, in vitro , and in silico experiments, underscoring their promising prospects for drug development. However, despite preliminary in vivo experimental data supporting their efficacy, a dearth of systematic clinical studies exists to further validate the safety and efficacy of these compounds in humans. Flavonoid-based drugs show promising antiviral activity against enteroviruses, but further research is needed to improve their therapeutic potential for future clinical applications.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, J., Zhao, Y., Chen, X., Li, Y., Kang, L., & Liu, Y. (2025). The antiviral properties of flavonoids. Clinical Traditional Medicine and Pharmacology, 6(1), 200192. https://doi.org/10.1016/j.ctmp.2024.200192
Vancouver
Chen J, Zhao Y, Chen X, Li Y, Kang L, Liu Y. The antiviral properties of flavonoids. Clinical Traditional Medicine and Pharmacology. 2025;6(1):200192. doi:10.1016/j.ctmp.2024.200192
BibTeX
@article{Chen2025,
author = {Chen, Jing and Zhao, Yi and Chen, Xiao and Li, Yadi and Kang, Li and Liu, Yuwei},
title = {The antiviral properties of flavonoids},
journal = {Clinical Traditional Medicine and Pharmacology},
year = {2025},
volume = {6},
number = {1},
pages = {200192},
doi = {10.1016/j.ctmp.2024.200192}
}
EUVIMED